BioAtla (BCAB) Return on Capital Employed (2021 - 2025)

BioAtla's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 501.5% for Q4 2025.

• On a quarterly basis, Return on Capital Employed rose 67431.0% year-over-year to 501.5% in Q4 2025; TTM through Dec 2025 was 501.5%, a 67431.0% increase from a year earlier, with the FY2025 full-year figure at 922.1%, down 81869.0% from the prior year.
• Return on Capital Employed advanced to 501.5% in Q4 2025 per BCAB's latest filing, from 1875.63% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 501.5% in Q4 2025 and bottomed at 1875.63% in Q3 2025.
• The 5-year median for Return on Capital Employed is 67.98% (2023), against an average of 170.05%.
• Biggest YoY gain for Return on Capital Employed was 67431 bps in 2025; the steepest drop was 168806 bps in 2025.
• Year by year, Return on Capital Employed stood at 39.17% in 2021, then slumped by 50 bps to 58.68% in 2022, then tumbled by 106 bps to 121.02% in 2023, then sank by 43 bps to 172.81% in 2024, then surged by 390 bps to 501.5% in 2025.
• Per Business Quant, the three latest BCAB Return on Capital Employed figures stand at 501.5% (Q4 2025), 1875.63% (Q3 2025), and 395.88% (Q2 2025).